David A. Butler

532 total citations
18 papers, 399 citations indexed

About

David A. Butler is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, David A. Butler has authored 18 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Molecular Medicine and 6 papers in Epidemiology. Recurrent topics in David A. Butler's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (5 papers). David A. Butler is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (5 papers). David A. Butler collaborates with scholars based in United States, United Kingdom and Ireland. David A. Butler's co-authors include Eric Wenzler, Mark Biagi, Helen Newell, Daryl R. Williams, Frank Thielmann, Graham Buckton, Xing Tan, Shitalben Patel, Migyung Lee and K.C. Waugh and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Pharmaceutical Research and Journal of Antimicrobial Chemotherapy.

In The Last Decade

David A. Butler

17 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Butler United States 9 184 131 74 70 63 18 399
Paritosh Prasad United States 8 157 0.9× 102 0.8× 96 1.3× 65 0.9× 196 3.1× 15 574
Rajnikant Sharma United States 13 273 1.5× 113 0.9× 35 0.5× 33 0.5× 55 0.9× 33 512
Yulin Zhang China 13 191 1.0× 59 0.5× 39 0.5× 45 0.6× 153 2.4× 54 491
Yanqin Huang China 14 137 0.7× 122 0.9× 35 0.5× 43 0.6× 55 0.9× 41 542
Sabine Schuster Germany 15 475 2.6× 161 1.2× 35 0.5× 14 0.2× 135 2.1× 21 737
Bernhard Mayer‐Helm Austria 13 94 0.5× 181 1.4× 30 0.4× 17 0.2× 86 1.4× 20 683
Elena N. Strukova Russia 12 242 1.3× 242 1.8× 21 0.3× 69 1.0× 49 0.8× 44 412
Sangrim Kang South Korea 13 233 1.3× 418 3.2× 89 1.2× 64 0.9× 219 3.5× 21 853
Satoshi Minami Japan 15 302 1.6× 228 1.7× 224 3.0× 34 0.5× 68 1.1× 37 803
Youngjoon Lim South Korea 9 414 2.3× 65 0.5× 63 0.9× 90 1.3× 59 0.9× 19 647

Countries citing papers authored by David A. Butler

Since Specialization
Citations

This map shows the geographic impact of David A. Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Butler more than expected).

Fields of papers citing papers by David A. Butler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Butler. The network helps show where David A. Butler may publish in the future.

Co-authorship network of co-authors of David A. Butler

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Butler. A scholar is included among the top collaborators of David A. Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Butler. David A. Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Butler, David A., Nimish Patel, J. Nicholas O’Donnell, & Thomas P. Lodise. (2024). Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature. Journal of Antimicrobial Chemotherapy. 79(10). 2421–2459. 5 indexed citations
2.
Nguyen, Timothy, Bernard Camins, & David A. Butler. (2024). Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis. American Journal of Therapeutics. 31(4). e398–e409. 2 indexed citations
3.
Butler, David A., et al.. (2023). Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration. Clinical Therapeutics. 45(11). 1137–1141.
4.
Wenzler, Eric, David A. Butler, Xing Tan, Takayuki Katsube, & Toshihiro Wajima. (2021). Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy. Clinical Pharmacokinetics. 61(4). 539–552. 30 indexed citations
5.
Butler, David A., Fiorella Krapp, Shitalben Patel, et al.. (2020). Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6’)-Ib. Journal of Antimicrobial Chemotherapy. 76(3). 671–679. 13 indexed citations
6.
Butler, David A., Mark Biagi, Vikas Gupta, et al.. (2020). Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance data. Infection Control and Hospital Epidemiology. 41(12). 1409–1418. 5 indexed citations
7.
Butler, David A., et al.. (2019). Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat. Current Infectious Disease Reports. 21(12). 46–46. 52 indexed citations
8.
Biagi, Mark, et al.. (2019). A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia. Antibiotics. 8(1). 27–27. 17 indexed citations
9.
Biagi, Mark, David A. Butler, Shitalben Patel, et al.. (2019). Pharmacokinetics and Dialytic Clearance of Isavuconazole during In Vitro and In Vivo Continuous Renal Replacement Therapy. Antimicrobial Agents and Chemotherapy. 63(12). 12 indexed citations
10.
11.
Biagi, Mark, David A. Butler, & Eric Wenzler. (2019). AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window. The Journal of Applied Laboratory Medicine. 3(4). 743–746. 8 indexed citations
12.
Butler, David A., et al.. (2017). Analysis and Interpretation of Registry Health Outcome Data. 1 indexed citations
13.
Potter, Murray A., et al.. (2015). Acoustic differences enable sex discrimination in Ma'oma'o ( Gymnomyza samoensis ), a species with high sexual morphological overlap. The Wilson Journal of Ornithology. 127(3). 376–386. 3 indexed citations
14.
Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2001). Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study. European Journal of Clinical Microbiology & Infectious Diseases. 20(11). 814–819. 13 indexed citations
15.
Newell, Helen, Graham Buckton, David A. Butler, Frank Thielmann, & Daryl R. Williams. (2001). The Use of Inverse Phase Gas Chromatography to Measure the Surface Energy of Crystalline, Amorphous, and Recently Milled Lactose. Pharmaceutical Research. 18(5). 662–666. 116 indexed citations
16.
Waugh, K.C., David A. Butler, & Brian E. Hayden. (1994). On the mechanism of poisoning and promotion of ammonia synthesis. Topics in Catalysis. 1(3-4). 295–301. 5 indexed citations
17.
Waugh, K.C., David A. Butler, & Brian E. Hayden. (1994). The mechanism of the poisoning of ammonia synthesis catalysts by oxygenates O2, CO and H2O: an in situ method for active surface determination. Catalysis Letters. 24(1-2). 197–210. 26 indexed citations
18.
Waugh, K.C., David A. Butler, & Brian E. Hayden. (1994). Promotion in ammonia synthesis: A pressure dependent phenomenon. Topics in Catalysis. 1(1-2). 43–61. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paritosh Prasad Breakdown of academic impact, for papers by Rajnikant Sharma Breakdown of academic impact, for papers by Yulin Zhang Breakdown of academic impact, for papers by Yanqin Huang Breakdown of academic impact, for papers by Sabine Schuster Breakdown of academic impact, for papers by Bernhard Mayer‐Helm Breakdown of academic impact, for papers by Elena N. Strukova Breakdown of academic impact, for papers by Sangrim Kang Breakdown of academic impact, for papers by Satoshi Minami Breakdown of academic impact, for papers by Youngjoon Lim
Rankless by CCL
2026